High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma.

Falzetti, Franca; Di Ianni, Mauro; Ballanti, Stelvio; Iodice, Giuseppe; Reale, Antonia; Minelli, Olivia; Serio, Gabriella; Martelli, Massimo F; Dammacco, Franco; Vacca, Angelo; Ria, Roberto

Falzetti, Franca; Di Ianni, Mauro; Ballanti, Stelvio; Iodice, Giuseppe; Reale, Antonia; Minelli, Olivia; Serio, Gabriella; Martelli, Massimo F; Dammacco, Franco; Vacca, Angelo; Ria, Roberto.

Affiliation

Falzetti F; Department of Clinical and Experimental Medicine, Section of Hematology and Clinical Immunology, University of Perugia Medical School, Perugia, Italy.

Clin Exp Med ; 12(3): 165-71, 2012 Sep.

Article de En | MEDLINE | ID: mdl-21928053

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome malin non hodgkinien / Carboplatine / Thiotépa / Conditionnement pour greffe / Transplantation de cellules souches / Étoposide Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Clin Exp Med Sujet du journal: MEDICINA Année: 2012 Type de document: Article Pays d'affiliation: Italie Pays de publication: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google